Treatment for the most common form of cancer (lung cancer) has historically involved use of cytotoxic chemotherapy. With the advent of mutation analysis, more therapies beyond traditional cytotoxics have been discovered. Most recently, the use of immunotherapy has entered the treatment arsenal of non-small cell lung cancer (NSCLC). This review aims to summarize the current and future use of immunotherapy in the treatment of NSCLC.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4630527 | PMC |
| http://dx.doi.org/10.3978/j.issn.2218-6751.2015.06.05 | DOI Listing |
Publication Analysis
Top Keywords
lung cancer
12
non-small cell
8
cell lung
8
strategies immunotherapy
4
immunotherapy non-small
4
cancer
4
cancer treatment
4
treatment common
4
common form
4
form cancer
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!